Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Metabolomics Services Market: By Service, By Sample Type, By Sample Source, By End User and Region Forecast 2019-2030
Metabolomics Services Market size was valued at US$ 111.5 million in 2023, and is projected to grow at a CAGR of 12.5% from 2024-2030. The study and analysis of biochemical processes including metabolic intermediates and byproducts are known as metabolomics. Metabolomes are a phrase used to describe a collection of all metabolites engaged in various processes in an organism, including metabolic intermediates, signaling molecules, secondary metabolites, and hormones.
By product segment, the largest market for metabolomics is metabolomics bioinformatics services and the segment is expected to expand at the highest CAGR throughout the projected period due to a large number of users of metabolomics analysis tools and services and the increasing need for data management. Moreover, players are focusing on acquisition for better growth in the market.
For instance, in 2020, Danaher Corporation entered into a definitive agreement with General Electric Company to acquire the Biopharma business of GE Life Sciences. Some of the major factors that will likely accelerate the growth of the market in the projected timeframe are an increase in the number of patients suffering from neurological disorders, cancer, and cardiac diseases, increasing growth of the healthcare industry across the globe, increasing demand for personalized medicine, and an increase in the need for accurate disease diagnosis.
In July 2021, Thermo Fisher Scientific, Inc. and the University of California, Davis (UC Davis) launched the Center of Excellence in Clinical Metabolomics, a research collaboration to provide innovations, best practices, and standard operating procedures to the metabolomics community.
Study Period
2024-2030Base Year
2023CAGR
12.5%Largest Market
Asia PacificFastest Growing Market
North America
The market is expected to offer lucrative opportunities due to the increased prevalence of certain types of cancers across the globe. According to data released by the World Health Organization (WHO) in September 2021, approximately 70% of cancer deaths occurred in low- and middle-income countries throughout the world. Moreover, growing interest towards personalized medicines and identifying novel drug targets also immense boost to the market. For instance, according to a research study, in the United States, the percentage of patients for whom a drug is ineffective is high in case of cancer drugs (75%) and Alzheimer's drugs (70%). The top 10 highest grossing drugs help only up to 25% of the people who take them and the statins which are used to lower cholesterol only benefit 2% of the patients.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 111.5 million |
Market CAGR |
12.5% |
By Service Type |
|
By Sample Type |
|
By Sample Source |
|
By End User |
|
By Region |
|
Download Free Sample Report
The global metabolomics services market size was valued at US$ 111.5 million in 2023 and is projected to grow at a CAGR of 12.5% from 2024 to 2030.
The major key players operating in the market are, Waters Corporation (US), Agilent Technologies (US), Shimadzu Corporation (Japan), Thermo Fisher Scientific (US), Danaher Corporation (US), Bruker Corporation (US), PerkinElmer (US), Merck KGaA (Germany), GE Healthcare (US), Hitachi High-Technologies Corporation (Japan), Human Metabolome Technologies, Inc. (Japan), LECO Corporation (US)
North America is the fastest-growing region for metabolomics services market
1. Executive Summary |
2. Global Metabolomics Services Market Introduction |
2.1. Global Metabolomics Services Market - Taxonomy |
2.2. Global Metabolomics Services Market -Definitions |
2.2.1. Service Type |
2.2.2. Sample Type |
2.2.3. Sample Source |
2.2.4. End User |
2.2.5. Region |
3. Global Metabolomics Services Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Collaborations, Acquisitions and Mergers |
3.6. Global Metabolomics Services Market - Competition Landscape |
3.7. Global Metabolomics Services Market Dynamic Factors - Impact Analysis |
4. Global Metabolomics Services Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Metabolomics Services Market, By Service Type, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.1. Separation and Detection |
5.1.1. Lipidomics |
5.1.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.1.3. Market Opportunity Analysis |
5.1.2. Untargeted Metabolite Assays |
5.1.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.2.3. Market Opportunity Analysis |
5.1.3. Targeted Metabolite Assays |
5.1.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3.3. Market Opportunity Analysis |
5.2. Bioinformatics |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6. Global Metabolomics Services Market Forecast, By Sample Type, 2019 - 2023 and Forecast, 2024 - 2030 |
6.1. Urine |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Blood |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Tumor |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Cell Culture |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Food Ingredients |
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
6.6. Feces |
6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7. Market Opportunity Analysis Global Metabolomics Services Market Forecast, By Sample Source, 2019 - 2023 and Forecast, 2024 - 2030 |
7.1. Human |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Animal |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Others |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8. Global Metabolomics Services Market Forecast, By End User, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.1. Healthcare Industry |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Academic and Research Institutes |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Food Processing Industry |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Others |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
9. Global Metabolomics Services Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.1. North America |
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia-Pacific |
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Latin America |
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Middle East and Africa |
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
9.6. Global Metabolomics Services Market - Opportunity Analysis Index, By Service Type, By Sample Type, By Sample Source, By End User, and Region, 2024 - 2030 |
10. North America Metabolomics Services Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
10.1. Service Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Separation and Detection |
10.1.1.1. Lipidomics |
10.1.1.2. Untargeted Metabolite Assays |
10.1.1.3. Targeted Metabolite Assays |
10.1.2. Bioinformatics |
10.2. Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.2.1. Urine |
10.2.2. Blood |
10.2.3. Tumor |
10.2.4. Cell Culture |
10.2.5. Food Ingredients |
10.2.6. Feces |
10.3. Sample Source Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Human |
10.3.2. Animal |
10.3.3. Others |
10.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.4.1. Healthcare Industry |
10.4.2. Food Processing Industry |
10.4.3. Academic Research Institutes |
10.4.4. Others |
10.5. Country Analysis 2016 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.5.1. U.S. |
10.5.2. Canada |
10.6. North America Metabolomics Services Market - Opportunity Analysis Index, By Service Type, By Sample Type, By Sample Source, By End User, and Country, 2024 - 2030 |
10.7. North America Metabolomics Services Market Dynamics - Trends |
11. Europe Metabolomics Services Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
11.1. Service Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Separation and Detection |
11.1.1.1. Lipidomics |
11.1.1.2. Untargeted Metabolite Assays |
11.1.1.3. Targeted Metabolite Assays |
11.1.2. Bioinformatics |
11.2. Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.2.1. Urine |
11.2.2. Blood |
11.2.3. Tumor |
11.2.4. Cell Culture |
11.2.5. Food Ingredients |
11.2.6. Feces |
11.3. Sample Source Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Human |
11.3.2. Animal |
11.3.3. Others |
11.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.4.1. Healthcare Industry |
11.4.2. Food Processing Industry |
11.4.3. Academic Research Institutes |
11.4.4. Others |
11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.5.1. Germany |
11.5.2. UK |
11.5.3. France |
11.5.4. Spain |
11.5.5. Italy |
11.5.6. Russia |
11.5.7. Poland |
11.5.8. Rest of Europe |
11.6. Europe Metabolomics Services Market - Opportunity Analysis Index, By Service Type, By Sample Type, By Sample Source, By End User, and Country, 2024 - 2030 |
11.7. Europe Metabolomics Services Market Dynamics - Trends |
12. Asia-Pacific Metabolomics Services Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
12.1. Service Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Separation and Detection |
12.1.1.1. Lipidomics |
12.1.1.2. Untargeted Metabolite Assays |
12.1.1.3. Targeted Metabolite Assays |
12.1.2. Bioinformatics |
12.2. Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.2.1. Urine |
12.2.2. Blood |
12.2.3. Tumor |
12.2.4. Cell Culture |
12.2.5. Food Ingredients |
12.2.6. Feces |
12.3. Sample Source Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Human |
12.3.2. Animal |
12.3.3. Others |
12.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Healthcare Industry |
12.4.2. Food Processing Industry |
12.4.3. Academic Research Institutes |
12.4.4. Others |
12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.5.1. Japan |
12.5.2. China |
12.5.3. India |
12.5.4. ASEAN |
12.5.5. Australia & New Zealand |
12.5.6. Rest of Asia-Pacific |
12.6. Asia-Pacific Metabolomics Services Market - Opportunity Analysis Index, By Service Type, By Sample Type, By Sample Source, By End User, and Country, 2024 - 2030 |
12.7. Asia-Pacific Metabolomics Services Market Dynamics - Trends |
13. Latin America Metabolomics Services Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
13.1. Service Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Separation and Detection |
13.1.1.1. Lipidomics |
13.1.1.2. Untargeted Metabolite Assays |
13.1.1.3. Targeted Metabolite Assays |
13.1.2. Bioinformatics |
13.2. Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.2.1. Urine |
13.2.2. Blood |
13.2.3. Tumor |
13.2.4. Cell Culture |
13.2.5. Food Ingredients |
13.2.6. Feces |
13.3. Sample Source Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.3.1. Human |
13.3.2. Animal |
13.3.3. Others |
13.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.4.1. Healthcare Industry |
13.4.2. Food Processing Industry |
13.4.3. Academic Research Institutes |
13.4.4. Others |
13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
13.5.1. Brazil |
13.5.2. Mexico |
13.5.3. Rest of Latin America |
13.6. Latin America Metabolomics Services Market - Opportunity Analysis Index, By Service Type, By Sample Type, By Sample Source, By End User, and Country, 2024 - 2030 |
13.7. Latin America Metabolomics Services Market Dynamics - Trends |
14. Middle East and Africa Metabolomics Services Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
14.1. Service Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.1.1. Separation and Detection |
14.1.1.1. Lipidomics |
14.1.1.2. Untargeted Metabolite Assays |
14.1.1.3. Targeted Metabolite Assays |
14.1.2. Bioinformatics |
14.2. Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.2.1. Urine |
14.2.2. Blood |
14.2.3. Tumor |
14.2.4. Cell Culture |
14.2.5. Food Ingredients |
14.2.6. Feces |
14.3. Sample Source Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.3.1. Human |
14.3.2. Animal |
14.3.3. Others |
14.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.4.1. Healthcare Industry |
14.4.2. Food Processing Industry |
14.4.3. Academic Research Institutes |
14.4.4. Others |
14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
14.5.1. Gulf Cooperation Council (GCC) Countries |
14.5.2. Israel |
14.5.3. South Africa |
14.5.4. Rest of MEA |
14.6. MEA Metabolomics Services Market - Opportunity Analysis Index, By Service Type, By Sample Type, By Sample Source, By End User, and Country, 2024 - 2030 |
14.7. MEA Metabolomics Services Market Dynamics - Trends |
15. Competition Landscape |
15.1. Strategic Dashboard of Top Market Players |
15.2. Company Profiles (Introduction, Financial Analysis, Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
15.2.1. Owl Metabolomics. (Spain), |
15.2.2. Metabolon, Inc. (U.S.), |
15.2.3. Metanomics health (Germany) |
15.2.4. Creative Untargeted Metabolite Analysis (U.S.), |
15.2.5. SteminaBiomarker Discovery, Inc. (U.S.), |
15.2.6. TMIC (Canada) |
15.2.7. West Coast Metabolomics Center (U.S.) |
15.2.8. Lipotype GmbH. (Germany) |
15.2.9. Chenomx Inc. (Canada) |
16. Research Methodology |
17. Key Assumptions and Acronyms |
Key Market Players